Asenapine versus placebo for schizophrenia-Reference-Cited by-同舟云学术

Asenapine versus placebo for schizophrenia

Published:2015-11-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hay Alistair¹,Byers Amy¹,Sereno Marco¹,Basra Manpreet Kaur¹,Dutta Snigdha¹

Affiliation:

1. The University of Nottingham; Institute of Mental Health; Jubilee Campus Innovation Park, Triumph Road Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference122 articles.

1. Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation;Chapel;Journal of Clinical Pharmacology,2009

2. Effect of asenapine versus quetiapine and placebo on QTc interval in patients with schizophrenia;Preskorn;European Neuropsychopharmacology,2007

3. Preskorn SH Chapel S Panagides J Effects of asenapine versus placebo on QTc interval in patients with schizophrenia American Psychiatric Association, 161st Annual Meeting, May 3-8, 2008, Washington, DC 2008

4. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic;Citrome;The International Journal of Clinical Practice,2009

5. Efficacy and safety of asenapine in patients with acute exacerbation of schizophrenia;Kane;Schizophrenia Research,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety assessment of asenapine in the FAERS database: real adverse event analysis and discussion on neurological and psychiatric side effects;BMC Pharmacology and Toxicology;2024-08-12

2. Predictors of continuation for asenapine from real-world data in patients with schizophrenia;Annals of General Psychiatry;2024-08-02

3. An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs;Neuroscience & Biobehavioral Reviews;2023-12

4. Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data;Neuropsychopharmacology Reports;2023-11-05

5. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms;Pharmaceuticals;2021-06-29